Drug intelligence / Profile preview

pantoprazole + amoxicillin + clarithromycin + metronidazole

Development stage
Phase 4
Lead developer
Veterans General Hospital Kaohsiung
Modality
Small Molecules
Administration
Oral
01

Overview

This 10-day sequential therapy is a specific treatment regimen developed and evaluated at Kaohsiung Veterans General Hospital for the eradication of *Helicobacter pylori* infection. The regimen is structured into two distinct phases: the first 5 days involve the administration of a proton pump inhibitor (pantoprazole 40 mg twice daily) and amoxicillin (1 g twice daily); the subsequent 5 days consist of the proton pump inhibitor (pantoprazole 40 mg twice daily) combined with clarithromycin (500 mg twice daily) and metronidazole (500 mg twice daily). This sequential approach is designed to improve eradication rates by first reducing the bacterial load and weakening the cell wall with amoxicillin, thereby enhancing the efficacy of clarithromycin and metronidazole in the second phase, particularly in populations with high antibiotic resistance.

Other names
10-day sequential therapysequential therapy
02

Targets

H. pylori 50S subunit (Helicobacter pylori 50S ribosomal subunit)ATP4A (Potassium–transporting ATPase alpha chain 1)Bacterial 50S ribosomal subunitDNAPBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on pantoprazole + amoxicillin + clarithromycin + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pantoprazole + amoxicillin + clarithromycin + metronidazole.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call